Stiff and loose at the same time: the laxity problem no tightening device targets

There is a description that comes up constantly in consultations and almost never in marketing copy. The skin is loose, and it also feels tough. It does not drape softly. Pinched, it lifts as a stiff fold rather than a soft one, and it snaps back sluggishly. Patients describe it as leathery, or say their skin feels like it has lost its give rather than its firmness.

That combination is not what collagen loss alone predicts. Losing structural protein should produce skin that is thinner, softer and slacker. Skin that is simultaneously slack and stiff is describing a change in the quality of the matrix rather than only the quantity of it, and the mechanism most likely responsible is one that no device sold for skin tightening addresses.

The original element in this piece is a statement of the specific evidence gap, namely that every commercial energy based tightening device is validated against displacement based measures of laxity and none has been shown to reverse glycation crosslinks, paired with a two part self assessment that separates skin quantity from skin quality so you can tell which problem you are actually shopping for. The two problems look identical in a mirror, respond differently to every available treatment, and are routinely quoted the same treatment plan.

What glycation does to the dermis. Glycation is a non enzymatic reaction in which sugars bind to proteins and, over time, form advanced glycation end products. In long lived structural proteins the consequence is crosslinking: adjacent fibers become chemically tethered to one another. Collagen in the dermis has a slow turnover, measured in years, which makes it one of the most exposed proteins in the body to a process that accumulates with time and with circulating glucose. Crosslinked collagen is stiffer, less soluble, and less able to be remodeled by the enzymes that would normally break it down and replace it. The emerging literature on glycation end products in cutaneous aging is where this has been drawn together for dermatology specifically, and the same chemistry is well characterized in vascular tissue, where crosslinking is used as a biomarker of arterial stiffening.

There is a pigment consequence as well, which is why this shows up in more than one complaint. Work showing that advanced glycation end products promote melanogenesis offers a plausible link between the same process and the dull, uneven, slightly sallow tone that frequently accompanies stiff skin and that responds poorly to brightening.

Why this matters for what you buy. Radiofrequency and ultrasound devices work by depositing controlled thermal injury at a chosen depth to provoke a wound healing response, which produces new collagen. That is a quantity intervention. It adds. The comparison between radiofrequency microneedling and focused ultrasound is a comparison of two ways of adding, at different depths, by different mechanisms of heating.

Neither cuts existing crosslinks. There is no cosmetic device, and no topical with meaningful human evidence, demonstrated to break advanced glycation end product crosslinks in dermal collagen and restore its mechanical properties. That is not a criticism of the devices. It is a statement about what they were designed to do. If your dominant problem is that the matrix you have is stiff and unremodelable rather than that you have too little of it, adding new collagen into a stiff scaffold produces a smaller visible change than the before and after gallery led you to expect, and the disappointment that follows is usually attributed to the device or the operator.

Part one of the self assessment: the drape test. Stand in front of a mirror in even light, face relaxed, and look at how the tissue along the jawline and under the chin hangs. Then tilt your head back forty five degrees and look again. What you are measuring here is quantity. Tissue that hangs when upright and disappears entirely when the head tilts back is excess and descent, which is the laxity that surgical and energy based lifting address most directly, and which sits behind the usual sorting between non surgical and surgical tightening.

Part two: the fold quality test. This is the one that gets skipped. Pinch a fold of skin on the outer cheek, over the jaw angle, between thumb and index finger. Do not time the release, which is the recoil test and answers a different question. Instead, pay attention to two things while the fold is held. First, how much force it took to lift it. Second, whether the fold has a soft rounded profile or a stiff ridged one with a defined crease at its base. Then repeat on the inner upper arm, which is comparatively protected from sun, and on the skin over the sternum, which is not.

Soft, easily lifted, rounded folds that release slowly describe a quantity problem. Folds that resist lifting, hold a sharp crease and feel like a different material than the protected inner arm describe a quality problem. Most people over fifty have some of both. The ratio is what tells you how much to expect from a device.

What the studies do not tell you. This is the honest limit and it is a large one. Nearly all clinical outcome data for cosmetic tightening devices uses either blinded photographic assessment or displacement based instrumentation, meaning a probe pulls the skin and measures how far it moves and how quickly it returns. Neither of those isolates crosslink density. No cosmetic device trial has measured advanced glycation end products in dermal tissue before and after treatment as a primary endpoint. So the claim that devices do not reverse glycation is not a negative finding from a trial that looked for it. It is the observation that the question has essentially never been asked in this population, which is a weaker and more accurate statement.

The same caution applies in the other direction, and it is worth stating because the supplement market is already ahead of the evidence here. There are no human trials establishing that any oral or topical product measurably reduces existing dermal crosslinks, and the general problems with the collagen supplement literature apply with more force to anti glycation claims, which are largely built on cell culture and animal work.

The takeaway is practical. If your skin is loose and soft, energy based tightening is aimed at your problem and the published expectations are reasonable. If it is loose and stiff, part of what you are seeing is a change in the material itself, no available treatment reverses that part, and the only interventions with real support are the slow ones: sun protection, glycemic control, not smoking. That is a less satisfying sentence than any device brochure, and it is the one the evidence currently supports.